Fingerprint
Dive into the research topics of 'Phase i trial of the human double minute 2 inhibitor MK-8242 in patients with advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i trial of the human double minute 2 inhibitor MK-8242 in patients with advanced solid tumors
Andrew J. Wagner, Udai Banerji, Amit Mahipal, Neeta Somaiah, Heather Hirsch, Craig Fancourt, Amy O. Johnson-Levonas, Raymond Lam, Amy K. Meister, Giuseppe Russo, Clayton D. Knox, Shelonitda Rose, David S. Hong
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations